Want to join the conversation?
$BAX 2Q15 PR: Segment Sales: Sales within Medical Products totaled $2.5Bil, a decline of 9%. Excluding impact of FX, Medical Products sales were comparable to prior year. On a reported basis, BioScience sales of $1.4Bil declined 2% compared to 2Q14. Excluding impact of FX, BioScience sales increased 7% driven by solid growth across the portfolio.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?